Stock Screener App

Frei -

Installieren

2.36

4.42% 0.10

after-market

Handel nachbörslich: 2.34 -0.02 -0.85%

Ovid Therapeutics Inc (OVID)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Ovid Therapeutics Inc-Aktie (OVID)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-07-01	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.132	-	0.13	0.076	0.173
Operating Expenses	12.65	-	12.68	10.80	13.40
Benefits Costs and Expenses	12.29	-	10.37	9.329	14.18
Costs And Expenses	12.29	-	10.37	9.329	14.18
Operating Income/Loss	-12.52	-	-12.55	-10.72	-13.23
Income/Loss From Continuing Operations Before Tax	159.56% -12.16	-4.684	-10.23	-9.253	-14.01
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	159.56% -12.16	-4.684	-10.23	-9.253	-14.01
Net Income/Loss	159.56% -12.16	-4.684	-10.23	-9.253	-14.01
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-0.458	-

ROIV

$30.41

1.27%

MRNA

$55.40

6.27%

BNTX

$89.50

1.43%

RPRX

$54.21

0.11%

ONC

$263.92

1.60%

RVMD

$156.58

2.17%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters